Lista de

depression
71
"Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients" (2019) Abulafia, C.;Fiorentini, L.;Loewenstein, D.A. (...)Guinjoan, S.M. Journal of Psychiatric Research. 112:23-29
"Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression" (2018) Carrillo, F.;Sigman, M.;Fernández Slezak, D. (...)Carhart-Harris, R.L. Journal of Affective Disorders. 230:84-86
"Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment" (2018) Campolongo, M.;Kazlauskas, N.;Falasco, G. (...)Depino, A.M. Molecular Autism. 9(1)
"Perinatal inflammation and adult psychopathology: From preclinical models to humans" (2018) Depino, A.M. Seminars in Cell and Developmental Biology. 77:104-114
"Perinatal inflammation and adult psychopathology: From preclinical models to humans" (2018) Depino, A.M. Seminars in Cell and Developmental Biology. 77:104-114
"Perinatal inflammation and adult psychopathology: From preclinical models to humans" (2018) Depino, A.M. Seminars in Cell and Developmental Biology. 77:104-114
"Perinatal inflammation and adult psychopathology: From preclinical models to humans" (2018) Depino, A.M. Seminars in Cell and Developmental Biology. 77:104-114
"Bottom-up gamma maintenance in various disorders" (2018) Garcia-Rill, E.; Mahaffey, S.; Hyde, J.R.; Urbano, F.J. Neurobiology of Disease
"Activated by evoked released protons modulate synaptic transmission at the mouse calyx of held synapse" (2017) González-Inchauspe, C.; Urbano, F.J.; Di Guilmi, M.N.; Uchitel, O.D. Journal of Neuroscience. 37(10):2589-2599
"21-hydroxy-6,19-epoxyprogesterone: A promising therapeutic agent and a molecular tool for deciphering glucocorticoid action" (2016) Pecci, A.; Alvarez, L.D.; Presman, D.M.; Burton, G. Mini-Reviews in Medicinal Chemistry. 16
"Age moderates the association of depressive symptoms and unhealthy alcohol use in the National Guard" (2016) Sahker, E.; Acion, L.; Arndt, S. Addictive Behaviors. 63:102-106
"Sertraline for preventing mood disorders following traumatic brain injury a randomized clinical trial" (2016) Jorge, R.E.; Acion, L.; Burin, D.I.; Robinson, R.G. JAMA Psychiatry. 73(10):1041-1047
"Juvenile exposure to a high fat diet promotes behavioral and limbic alterations in the absence of obesity" (2016) Vinuesa, A.;Pomilio, C.;Menafra, M. (...)Saravia, F. Psychoneuroendocrinology. 72:22-33
"Altered gene expression in hippocampus and depressive-like behavior in young adult female mice by early protein malnutrition" (2016) Belluscio, L.M.; Alberca, C.D.; Pregi, N.; Cánepa, E.T. Genes, Brain and Behavior. 15(8):741-749
"Altered gene expression in hippocampus and depressive-like behavior in young adult female mice by early protein malnutrition" (2016) Belluscio, L.M.; Alberca, C.D.; Pregi, N.; Cánepa, E.T. Genes, Brain and Behavior. 15(8):741-749
"Altered gene expression in hippocampus and depressive-like behavior in young adult female mice by early protein malnutrition" (2016) Belluscio, L.M.; Alberca, C.D.; Pregi, N.; Cánepa, E.T. Genes, Brain and Behavior. 15(8):741-749
"Role of TGF-β1 in the behavior disorders" (2015) Depino, A.M. Advances in Neuroimmune Biology. 6(1):19-23
"Early protein malnutrition negatively impacts physical growth and neurological reflexes and evokes anxiety and depressive-like behaviors" (2014) Belluscio, L.M.;Berardino, B.G.;Ferroni, N.M. (...)Cánepa, E.T. Physiology and Behavior. 129:237-254
"Early protein malnutrition negatively impacts physical growth and neurological reflexes and evokes anxiety and depressive-like behaviors" (2014) Belluscio, L.M.;Berardino, B.G.;Ferroni, N.M. (...)Cánepa, E.T. Physiology and Behavior. 129:237-254
"Early protein malnutrition negatively impacts physical growth and neurological reflexes and evokes anxiety and depressive-like behaviors" (2014) Belluscio, L.M.;Berardino, B.G.;Ferroni, N.M. (...)Cánepa, E.T. Physiology and Behavior. 129:237-254
"Adherence to treatment in patients with ankylosing spondylitis" (2013) Arturi, P.;Schneeberger, E.E.;Sommerfleck, F. (...)Citera, G. Clinical Rheumatology. 32(7):1007-1015
"Preliminary evidence about the effects of meditation on interoceptive sensitivity and social cognition" (2013) Melloni, M.;Sedeño, L.;Couto, B. (...)Ibanez, A. Behavioral and Brain Functions. 9(1)
"Preliminary evidence about the effects of meditation on interoceptive sensitivity and social cognition" (2013) Melloni, M.;Sedeño, L.;Couto, B. (...)Ibanez, A. Behavioral and Brain Functions. 9(1)
"Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51" (2012) Galigniana, N.M.;Ballmer, L.T.;Toneatto, J. (...)Galigniana, M.D. Journal of Neurochemistry. 122(1):4-18
"Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51" (2012) Galigniana, N.M.;Ballmer, L.T.;Toneatto, J. (...)Galigniana, M.D. Journal of Neurochemistry. 122(1):4-18
"Disrupted functional connectivity of the pain network in fibromyalgia" (2012) Cifre, I.;Sitges, C.;Fraiman, D. (...)Montoya, P. Psychosomatic Medicine. 74(1):55-62
"Hippocampal SPARC regulates depression-related behavior" (2012) Campolongo, M.;Benedetti, L.;Podhajcer, O.L. (...)Depino, A.M. Genes, Brain and Behavior. 11(8):966-976
"Hippocampal SPARC regulates depression-related behavior" (2012) Campolongo, M.;Benedetti, L.;Podhajcer, O.L. (...)Depino, A.M. Genes, Brain and Behavior. 11(8):966-976
"Hippocampal SPARC regulates depression-related behavior" (2012) Campolongo, M.;Benedetti, L.;Podhajcer, O.L. (...)Depino, A.M. Genes, Brain and Behavior. 11(8):966-976
"Early and adult hippocampal TGF-β1 overexpression have opposite effects on behavior" (2011) Depino, A.M.; Lucchina, L.; Pitossi, F. Brain, Behavior, and Immunity. 25(8):1582-1591
"Early and adult hippocampal TGF-β1 overexpression have opposite effects on behavior" (2011) Depino, A.M.; Lucchina, L.; Pitossi, F. Brain, Behavior, and Immunity. 25(8):1582-1591
"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490
"The corticotropin-releasing hormone network and the hypothalamic-pituitary- adrenal axis: Molecular and cellular mechanisms involved" (2011) Bonfiglio, J.J.;Inda, C.;Refojo, D. (...)Silberstein, S. Neuroendocrinology. 94(1):12-20
"Emerging pharmacotherapy of tinnitus" (2011) Langguth, B.; Elgoyhen, A.B. Expert Opinion on Emerging Drugs. 16(4):603-606
"Emerging pharmacotherapy of tinnitus" (2009) Langguth, B.; Salvi, R.; Elgoyhen, A.B. Expert Opinion on Emerging Drugs. 14(4):687-702
"Emerging pharmacotherapy of tinnitus" (2009) Langguth, B.; Salvi, R.; Elgoyhen, A.B. Expert Opinion on Emerging Drugs. 14(4):687-702
"Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms" (2009) Frick, L.R.; Rapanelli, M.; Cremaschi, G.A.; Genaro, A.M. Brain, Behavior, and Immunity. 23(1):36-40
"Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms" (2009) Frick, L.R.; Rapanelli, M.; Cremaschi, G.A.; Genaro, A.M. Brain, Behavior, and Immunity. 23(1):36-40
"Hesperidin, a flavonoid glycoside with sedative effect, decreases brain pERK1/2 levels in mice" (2009) Martínez, M.C.;Fernandez, S.P.;Loscalzo, L.M. (...)Viola, H. Pharmacology Biochemistry and Behavior. 92(2):291-296
"Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse" (2008) Beauquis, J.;Saravia, F.;Coulaud, J. (...)De Nicola, A. Experimental Neurology. 210(2):359-367
"Work status among patients with ankylosing spondylitis in Argentina" (2008) Marengo, M.F.; Schneeberger, E.E.; Citera, G.; Cocco, J.A.M. Journal of Clinical Rheumatology. 14(5):273-277
"Work status among patients with ankylosing spondylitis in Argentina" (2008) Marengo, M.F.; Schneeberger, E.E.; Citera, G.; Cocco, J.A.M. Journal of Clinical Rheumatology. 14(5):273-277
"Work status among patients with ankylosing spondylitis in Argentina" (2008) Marengo, M.F.; Schneeberger, E.E.; Citera, G.; Cocco, J.A.M. Journal of Clinical Rheumatology. 14(5):273-277
"CRF signaling: molecular specificity for drug targeting in the CNS" (2006) Arzt, E.; Holsboer, F. Trends in Pharmacological Sciences. 27(10):531-538
"Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: Reversion by antidepressant treatment" (2006) Beauquis, J.;Roig, P.;Homo-Delarche, F. (...)Saravia, F. European Journal of Neuroscience. 23(6):1539-1546
"New perspectives in the treatment of cushing's syndrome" (2004) Labeur, M.; Arzt, E.; Stalla, G.K.; Péz-Pereda, M. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 4(4):335-342
"Diagnosis, phenomenology and treatment of poststroke depression" (2002) Starkstein, S.E.; Lischinsky, A. Revista Brasileira de Psiquiatria. 24(1):44-49
"Diagnosis, phenomenology and treatment of poststroke depression" (2002) Starkstein, S.E.; Lischinsky, A. Revista Brasileira de Psiquiatria. 24(1):44-49
"Delayed intracerebral electrode infection after bilateral STN implantation for parkinson's disease" (2001) Merello, M.; Cammarota, A.; Leiguarda, R.; Pikielny, R. Movement Disorders. 16(1):168-170
"Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation" (2001) Merello, M.;Starkstein, S.;Nouzeilles, M.I. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 71(5):611-614
"The effect of melatonin in patients with fibromyalgia: A pilot study" (2000) Citera, G.;Arias, M.A.;Maldonado-Cocco, J.A. (...)Cardinalli, D.P. Clinical Rheumatology. 19(1):9-13
"Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease" (1997) Starkstein, S.E.;Sabe, L.;Vázquez, S. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 63(1):66-73
"Cognitive functions in major depression and Parkinson disease" (1997) Kuzis, G.;Sabe, L.;Tiberti, C. (...)Starkstein, S.E. Archives of Neurology. 54(8):982-986
"A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease" (1996) Petracca, G.;Tesón, A.;Chemerinski, E. (...)Starkstein, S.E. Journal of Neuropsychiatry and Clinical Neurosciences. 8(3):270-275
"Classification of quantitative eeg data by an artificial neural network: A preliminary study" (1996) Riquelme, L.A.; Zanuto, B.S.; Murer, M.G.; Lombardo, R.J. Neuropsychobiology. 33(2):106-112
"Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia" (1996) Starkstem, S.E.;Sabe, L.;Petracca, G. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 61(4):381-387
"Catatonia in depression: Prevalence, clinical correlates, and validation of a scale" (1996) Starkstein, S.E.;Petracca, G.;Tesón, A. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 60(3):326-332
"Catatonia in depression: Prevalence, clinical correlates, and validation of a scale" (1996) Starkstein, S.E.;Petracca, G.;Tesón, A. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 60(3):326-332
"Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease" (1996) Starkstein, S.E.;Sabe, L.;Vázquez, S. (...)Leiguarda, R. Stroke. 27(3):408-414
"SPECT findings before and after ECT in a patient with major depression and Cotard's syndrome" (1995) Petracca, G.; Migliorelli, R.; Vazquez, S.; Starkstein, S.E. Journal of Neuropsychiatry and Clinical Neurosciences. 7(4):505-507
"Prevalence and clinical correlates of pathological affective display in Alzheimer's disease" (1995) Starkstein, S.E.;Migliorelli, R.;Teson, A. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 59(1):55-60
"Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease" (1995) Migliorelli, R.;Teson, A.;Sabe, L. (...)Starkstein, S.E. American Journal of Psychiatry. 152(1):37-44